Rapid Preoperative Preparation for Severe Hyperthyroid Graves' Disease

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 5, 2004, Pages 2142-2144

  Panzer, Claudia ^a   Beazley, Robert ^a   Braverman, Lewis ^a,b  

^a BOSTON MEDICAL CENTER   (United States)

^b Dept Endocrinol Diabet/Metab ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DEXAMETHASONE; IODINE 131; IOPANOIC ACID; LIOTHYRONINE; PROPYLTHIOURACIL; THIAMAZOLE; THYROXINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DEIODINATION; DISEASE SEVERITY; EUTHYROIDISM; EYE DISEASE; FEMALE; GOITER; GRAVES DISEASE; HUMAN; HYPOPARATHYROIDISM; INTRAOCULAR PRESSURE; LARYNGEAL NERVE; LIOTHYRONINE BLOOD LEVEL; MALE; NERVE INJURY; PATIENT COMPLIANCE; PREOPERATIVE CARE; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; SIDE EFFECT; THYROID FUNCTION TEST; THYROIDECTOMY; THYROTOXICOSIS; THYROXINE BLOOD LEVEL; TREATMENT INDICATION;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANTITHYROID AGENTS; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; GRAVES DISEASE; HUMANS; IOPANOIC ACID; MALE; METHIMAZOLE; PREOPERATIVE CARE; PROPYLTHIOURACIL; SEVERITY OF ILLNESS INDEX; THYROIDECTOMY; TIME FACTORS; TREATMENT OUTCOME; TRIIODOTHYRONINE;

EID: 2442568586     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031981     Document Type: Article

References (21)

1. Winsa B, Rastad J, Larsson E, Mandahl A, Westermark K, Johansson H, Juhlin C, Karlsson A, Akerstrom G 1994 Total thyroidectomy in therapy-resistant Graves' disease. Surgery 116:1068-1074; discussion 1074-1075
2. Patwardhan NA, Moront M, Rao S, Rossi S, Braverman LE 1993 Surgery still has a role in Graves' hyperthyroidism. Surgery 114:1108-1112; discussion 1112-1113
3. Pinchera A, Bartalena L, Marcocci C 1995 Therapeutic controversies. Radioiodine may be bad for Graves' ophthalmopathy, but.... J Clin Endocrinol Metab 80:342-345
4. Gorman CA 1995 Therapeutic controversies. Radioiodine therapy does not aggravate Graves' ophthalmopathy. J Clin Endocrinol Metab 80:340-342
5. Wu SY, Chopra IJ, Solomon DH, Bennett LR 1978 Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (Oragrafin), an agent for oral cholecystography. J Clin Endocrinol Metab 46: 691-697
6. Burgi H, Wimpfheimer C, Burger A, Zaunbauer W, Rosler H, Lemarchand-Beraud T 1976 Changes of circulating thyroxine, triindothyronine and reverse triiodothyronine after radiographic contrast agents. J Clin Endocrinol Metab 43:1203-1210
7. Braga M, Cooper DS 2001 Clinical review 129: oral cholecystographic agents and the thyroid. J Clin Endocrinol Metab 86:1853-1860
8. Fontanilla JC, Schneider AB, Same DH 2001 The use of oral radiographic contrast agents in the management of hyperthyroidism. Thyroid 11:561-567
9. Wiersinga WM, Braverman LE 2003 Iodine-induced thyroid disease. In: Braverman, L, ed. Diseases of the thyroid. Totawa, NJ: Humana Press; 347-362
10. Arteaga E, Lopez JM, Rodriguez JA, Michaud P, Lopez G 1983 Effect of the combination of dexamethasone and sodium ipodate on senun thyroid hormones in Graves' disease. Clin Endocrinol (Oxf) 19:619-627
11. Roti E, Robuschi G, Manfredi A, D'Amato L, Gardini E, Salvi M, Montermini M, Barlli AL, Gnudi A, Braverman LE 1985 Comparative effects of sodium ipodate and iodide on senun thyroid hormone concentrations in patients with Graves' disease. Clin Endocrinol (Oxf) 22:489-496
12. Felicetta JV, Green WL, Nelp WB 1980 Inhibition of hepatic binding of thyroxine by cholecystographic agents. J Clin Invest 65:1032-1040
13. Coyle PJ, Mitchell JE 1982 Thyroidectomy: is Lugol's iodine necessary? Ann R Coll Surg Engl 64:334-335
14. Chang DC, Wheeler MH, Woodcock JP, Curley I, Lazarus JR, Fung H, John R, Hall R, McGregor AM 1987 The effect of preoperative Lugol's iodine on thyroid blood flow in patients with Graves' hyperthyroidism. Surgery 102: 1055-1061
15. Tomaski SM, Mahoney EM, Burgess LP, Raines KB, Bornemann M 1997 Sodium ipodate (oragrafin) in the preoperative preparation of Graves' hyperthyroidism. Laryngoscope 107:1066-1070
16. 3). J Clin Endocrinol Metab 41:911-920
17. Roti E, Robuschi G, Gardini E, Montermini M, Salvi M, Manfredi A, Gnudi A, Braverman LE 1988 Comparison of methimazole, methimazole and sodium ipodate, and methimazole and saturated solution of potassium iodide in the early treatment of hyperthyroid Graves' disease. Clin Endocrinol (Oxf) 28: 305-314
18. Martino E, Balzano S, Bartalena L, Loviselli A, Sica V, Petrini L, Grasso L, Piga M, Braverman LE 1991 Therapy of Graves' disease with sodium ipodate is associated with a high recurrence rate of hyperthyroidism. J Endocrinol Invest 14:847-851
19. Berghout A, Wiersinga WM, Brummelkamp WH 1989 Sodium ipodate in the preparation of Graves' hyperthyroid patients for thyroidectomy. Horm Res 31:256-260
20. Bogazzi F, Miccoli P, Berti P, Cosci C, Brogioni S, Aghini-Lombardi F, Materazzi G, Bartalena L, Pinchera A, Braverman LE, Martino E 2002 Preparation with iopanoic acid rapidly controls thyrotoxicosis in patients with amiodarone-induced thyrotoxicosis before thyroidectomy. Surgery 132:1114-1117; discussion 1118
21. Baeza A, Aguayo J, Barria M, Pineda G 1991 Rapid preoperative preparation in hyperthyroidism. Clin Endocrinol (Oxf) 35:439-442